Medical regulator faces questions over board members’ links to drug firms | NHS

The UK medicines watchdog has been urged to strengthen its conflict of interest policy after it emerged that six of its board members are receiving payments from the pharmaceutical industry. Board members involved in overseeing the regulator’s “strategic direction” also have financial interests in companies including US and Saudi drug giants and firms with ambitions … Read more

A psychedelic pill for alcoholism? The CEO of Clearmind Medicine says ‘Yes.’

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Alcohol use disorder is a tough nut to crack when it comes to finding effective treatments. Alcohol is not only legal, but fully embedded and embraced in our culture, despite being one of the most addictive substances … Read more

I-MAK Defends Integrity of Its Patent Data in Response to Tillis Letter

“At the time of writing in 2018, 11 out of the 12 drugs did not have any generic or biosimilar competition in the United States. Even the drug that did have competition (Remicade) at the time of writing was limited to only one competitor.” I-MAK letter The Initiative for Medicines, Access & Knowledge (I-MAK) has … Read more